Learning Outcomes and Lectures
After completing this course, the learner should be able to:
Explain the impact of PET imaging on the diagnosis and understanding of dementia.
Discuss the benefits of novel imaging agents for oncology.
Describe the landscape of therapeutic radiopharmaceuticals.
Describe the role of nuclear medicine in theranostics.
Speakers and Lectures
Breakthroughs in PET for Neurodegenerative Diseases—P. Kuo
Breakthroughs in PET for Oncologic Imaging—K. Zukotynski
Breakthroughs in Radiotherapeutics and Theranostics—D. Yoo
50.00 $
ARRS Breakthroughs in Nuclear Medicine for Neurology and Oncology 2021 (CME VIDEOS)
3 videos File size : 300mb
ith the completion of several large clinical trials in nuclear medicine leading to significant breakthroughs for both dementia and cancer patients, this Online Course highlights PET imaging of proteinopathies for neurodegenerative disease, amyloid PET for dementia, FES-PET for breast cancer, as well as updates to treatments such as PRRT and Radium-223.
Earn credit at your own pace through June 13, 2024 and continue to access your videos until June 14, 2031
This course package offers 2 CME and SA-CME Credits following completion of an online test.
結果の1～12/340を表示しています
